HTH(HTH)
HTH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.25B | $1.30B |
| Low | $1.24B | $1.29B |
| High | $1.26B | $1.30B |
| EBITDA Avg | $200M | $207M |
| Low | $198M | $205M |
| High | $200M | $207M |
| EBIT Avg | $181M | $188M |
| Low | $180M | $187M |
| High | $182M | $188M |
| Net Income Avg | $150M | $150M |
| Low | $140M | $146M |
| High | $161M | $155M |
| EPS Avg | $2.38 | $2.39 |
| Low | $2.23 | $2.33 |
| High | $2.56 | $2.47 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $307M | $325M | $320M | $308M | $319M | $341M | $332M |
| Low | $298M | $322M | $313M | $301M | $312M | $334M | $324M |
| High | $315M | $328M | $327M | $314M | $325M | $348M | $338M |
| EBITDA Avg | $49M | $52M | $51M | $49M | $51M | $54M | $53M |
| Low | $47M | $51M | $50M | $48M | $50M | $53M | $52M |
| High | $50M | $52M | $52M | $50M | $52M | $55M | $54M |
| EBIT Avg | $44M | $47M | $46M | $45M | $46M | $49M | $48M |
| Low | $43M | $47M | $45M | $44M | $45M | $48M | $47M |
| High | $45M | $47M | $47M | $45M | $47M | $50M | $49M |
| Net Income Avg | $29M | $38M | $35M | $29M | $29M | $44M | $38M |
| Low | $26M | $35M | $34M | $29M | $29M | $43M | $37M |
| High | $35M | $44M | $36M | $30M | $30M | $45M | $39M |
| EPS Avg | $0.49 | $0.65 | $0.59 | $0.50 | $0.50 | $0.74 | $0.65 |
| Low | $0.44 | $0.59 | $0.58 | $0.48 | $0.48 | $0.72 | $0.63 |
| High | $0.59 | $0.74 | $0.61 | $0.51 | $0.51 | $0.76 | $0.67 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |